Inflammatory bowel disease rapid test 6118
for calprotectinclinicalstool

inflammatory bowel disease rapid test
inflammatory bowel disease rapid test
Add to favorites
Compare this product
 

Characteristics

Applications
inflammatory bowel disease
Tested parameter
for calprotectin
Sample type
clinical, stool, laboratory
Analysis mode
immunoassay, immunochromatographic
Result display time

10 min

Description

The Calprotectin Rapid is a qualitative immunoassay for the determination of Calprotectin in human stool samples. The Calprotectin Rapid intended as an aid in the diagnosis of inflammatory bowel disease in conjunction with other clinical and laboratory findings. The immunoassay is designed for manual professional in vitro diagnostic use. Diagnostic Relevance Inflammatory bowel disease (IBD) is diagnosed via the detection of faecal calprotectin. Calprotectin, mainly located in cytoplasmic neutrophil granulocytes, plays a major role in immune response following its releases after activation of neutrophils. The released calprotectin act as markers of inflammation evident by their presence in the serum, body fluids and faeces; thus acting as alternative marker of neutrophil entry into the intestinal lumen: In this way, organically induced intestinal diseases can be effectively differentiated from functional intestinal disorders like irritable bowel syndrome. Indication - Inflammatory bowel disease Description - Rapid immunochromatographic test for the determination of calprotectin in human stool samples Format - Test strips coated with monoclonal antibodies against calprotectin Incubation time - 10 min. Sample volume - 1-2 g/mL stool sample No. of determinations - 1 (1 x 1)

Catalogs

No catalogs are available for this product.

See all of MEDIPAN GmbH‘s catalogs
*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.